Changeflow GovPing Healthcare & Life Sciences Compression vs Antibiotics, 25 French Sites, Er...
Routine Notice Added Final

Compression vs Antibiotics, 25 French Sites, Erysipelas Study

Favicon for clinicaltrials.gov ClinicalTrials.gov - Phase 4 Trials
Detected
Email

Summary

This ClinicalTrials.gov registry entry documents a Phase 4 interventional study (NCT07549594) comparing compression therapy versus antibiotic treatment for erysipelas (cellulitis), a bacterial skin infection. The randomized, open-label, parallel-assignment trial is being conducted across 25 clinical sites in France and is registered under NIH's clinical trials database.

Published by NIH on clinicaltrials.gov . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

GovPing monitors ClinicalTrials.gov - Phase 4 Trials for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 10 changes logged to date.

What changed

The NIH ClinicalTrials.gov registry entry adds a new Phase 4 clinical trial (NCT07549594) to the public database. The study will evaluate whether compression therapy is non-inferior to standard antibiotic treatment for erysipelas, conducted as a randomized open-label trial across 25 sites in France.

For clinical investigators and healthcare providers: This trial represents a non-comparative effectiveness study that may generate data relevant to antibiotic stewardship protocols. Researchers conducting related infectious disease or dermatology studies should note the French site network for potential collaboration opportunities.

Archived snapshot

Apr 24, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

Show glossary

Get daily alerts for ClinicalTrials.gov - Phase 4 Trials

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from NIH.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
NIH
Instrument
Notice
Branch
Executive
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
NCT07549594

Who this affects

Applies to
Healthcare providers Clinical investigators
Industry sector
6211 Healthcare Providers
Activity scope
Clinical trial registration Medical research
Geographic scope
United States US

Taxonomy

Primary area
Public Health
Operational domain
Clinical Operations
Topics
Healthcare Pharmaceuticals

Get alerts for this source

We'll email you when ClinicalTrials.gov - Phase 4 Trials publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!